Hilton Head Capital Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Hilton Head Capital Partners's AMGN Position: Q2 2026 in Review
Hilton Head Capital Partners increased its Amgen (AMGN) stake by 1.8% in Q2 2026, buying an estimated $23.6K and bringing the position to 3,927 shares worth $1.42M. The position accounts for 0.72% of the portfolio, ranked #33.
Hilton Head Capital Partners first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Hilton Head Capital Partners held 3,927 shares of Amgen worth $1.42M as of Q2 2026.
- Hilton Head Capital Partners bought 69 Amgen shares in Q2 2026, an estimated $23.6K.
- Amgen made up 0.72% of Hilton Head Capital Partners's portfolio in Q2 2026, its #33 holding.
- Hilton Head Capital Partners first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Hilton Head Capital Partners's 13F filing for Q2 2026, filed 27 Jul 2026.